Hively Brad

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
8 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 1622%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Hively Brad's trades of Oncology Institute Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-16 2025-12-15
S Sale
3,993 +4.2%
73.09
US$2,798,270 		3,993 +4.2% 73.09 US$2,798,270
2025-12-15 2025-12-15
PrS Proposed sale
5,652
439.53
US$2,122,934 		5,652 439.53 US$2,122,934
2025-08-21 2025-08-19
S Sale
73,200 -3.2%
456.41
US$2,481,082 		73,200 -3.2% 456.41 US$2,481,082
2025-06-05 2025-06-03
S Sale
108,532 -15.2%
2.87
US$311,519 		108,532 -15.2% 2.87 US$311,519
2025-06-05 2025-06-03
S Sale
1,867,605 -72.4%
2.87
US$5,360,587 		1,867,605 -72.4% 2.87 US$5,360,587
2025-06-03 2025-06-03
PrS Proposed sale
39,600
2.87
US$113,652 		39,600 2.87 US$113,652
2025-06-03 2025-06-03
PrS Proposed sale
1,936,537
2.87
US$5,557,861 		1,936,537 2.87 US$5,557,861
2025-03-28 2025-03-26
B Purchase
9,056 +1.4%
1.04
US$9,434 		9,056 +1.4% 1.04 US$9,434
2024-12-02 2024-12-02
B Purchase
50,000 +8.1%
0.15
US$7,500 		50,000 +8.1% 0.15 US$7,500
2024-12-02 2024-11-26
B Purchase
250,000 +68.2%
0.17
US$42,500 		250,000 +68.2% 0.17 US$42,500
2023-11-21 2023-11-17
S Sale
25,000 -3.5%
2.24
US$56,000 		25,000 -3.5% 2.24 US$56,000
2023-11-17 2023-11-17
PrS Proposed sale
25,000
2.24
US$56,000 		25,000 2.24 US$56,000
2023-11-15 2023-11-13
S Sale
47,000 -6.1%
2.52
US$118,581 		47,000 -6.1% 2.52 US$118,581
2023-11-13 2023-11-13
PrS Proposed sale
47,000
2.52
US$118,589 		47,000 2.52 US$118,589